Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADAM17 | P78536 | 20/20 | 0.50 |
| ▸ | ADAM10 | O14672 | 3/20 | 0.46 |
| ▸ | MMP3 | P08254 | 2/20 | 0.46 |
| ▸ | ADAM9 | Q13443 | 1/20 | 0.45 |
| ▸ | MMP1 | P03956 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15327690 | 1.00 | ADAM17 (0.50) | ADAM17ADAM10MMP3ADAM9MMP1 | |
| SCHEMBL10276911 | 0.86 | ADAM17 (0.58) | ADAM17ADAM10MMP3ADAM9MMP1 | |
| SCHEMBL12077084 | 0.77 | ADAM17 (0.67) | ADAM17ADAM10MMP3ADAM9MMP1 | |
| SCHEMBL12077080 | 0.77 | ADAM17 (0.67) | ADAM17ADAM10MMP3ADAM9MMP1 | |
| SCHEMBL17019809 | 0.73 | ADAM17 (0.53) | ADAM17ADAM10MMP3ADAM9MMP1 | |
| SCHEMBL10276389 | 0.70 | ADAM17 (0.62) | ADAM17ADAM10MMP3ADAM9MMP1 | |
| SCHEMBL15327676 | 0.70 | ADAM17 (0.62) | ADAM17ADAM10MMP3ADAM9MMP1 | |
| SCHEMBL15936257 | 0.70 | ADAM17 (0.58) | ADAM17MMP3ADAM9MMP1 | |
| SCHEMBL1503560 | 0.69 | ADAM17 (0.85) | ADAM17ADAM10MMP3ADAM9MMP1 | |
| SCHEMBL1503563 | 0.69 | ADAM17 (0.85) | ADAM17ADAM10MMP3ADAM9MMP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2477969-A1 | 4-ALKOXY-N- (2-HYDROXYCARBAMOYL-2-PIPERIDINYL-ETHYL) -BENZAMIDE COMPOUNDS AS SELECTIVE TACE-INHIBITORS FOR THE TREATMENT OF INFLAMMATORY DISEASES | Galderma Research & Development (FR) | 2012-07-25 | — | — | EP | claimed |
| WO-2011033010-A1 | 4-ALKOXY-N- (2-HYDROXYCARBAMOYL-2-PIPERIDINYL-ETHYL) -BENZAMIDE COMPOUNDS AS SELECTIVE TACE-INHIBITORS FOR THE TREATMENT OF INFLAMMATORY DISEASES | GALDERMA RESEARCH & DEVELOPMENT (FR) | 2011-03-24 | — | — | WO | claimed |
| EP-2477969-A1 | 4-ALKOXY-N- (2-HYDROXYCARBAMOYL-2-PIPERIDINYL-ETHYL) -BENZAMIDE COMPOUNDS AS SELECTIVE TACE-INHIBITORS FOR THE TREATMENT OF INFLAMMATORY DISEASES | Galderma Research & Development (FR) | 2012-07-25 | — | — | EP | disclosed |
| WO-2011033010-A1 | 4-ALKOXY-N- (2-HYDROXYCARBAMOYL-2-PIPERIDINYL-ETHYL) -BENZAMIDE COMPOUNDS AS SELECTIVE TACE-INHIBITORS FOR THE TREATMENT OF INFLAMMATORY DISEASES | GALDERMA RESEARCH & DEVELOPMENT (FR) | 2011-03-24 | — | — | WO | disclosed |